BSX
What one share of Boston Scientific holds
Surgical and Medical Instruments and Apparatus
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world.
Boston Scientific’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $14.09 |
|---|---|
| Profit | $2.47 |
| Capex (buildings and equipment) | $0.61 |
| Free cash flow | $2.43 |
| Cash and investments | $0.37 |
| Debt | $7.53 |
| Book value | $17.20 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $6.59 | $0.25 | $0.27 | $0.59 | — | $4.94 |
| 2017 | $6.50 | $0.08 | $0.23 | $0.79 | — | $5.11 |
| 2018 | $7.01 | $1.19 | $0.23 | −$0.00 | — | $6.30 |
| 2019 | $7.61 | $3.33 | $0.33 | $0.97 | — | $9.95 |
| 2020 | $7.00 | −$0.08 | $0.27 | $0.80 | — | $10.81 |
| 2021 | $8.29 | $0.69 | $0.39 | $0.92 | — | $11.65 |
| 2022 | $8.81 | $0.45 | $0.41 | $0.65 | — | $12.25 |
| 2023 | $9.73 | $1.07 | $0.49 | $1.22 | — | $13.14 |
| 2024 | $11.27 | $1.25 | $0.53 | $1.78 | — | $14.75 |
| 2025 | $13.43 | $1.94 | $0.59 | $2.45 | — | $16.33 |